Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer

Vedlegg 1: Jon Sudbøs publikasjonsliste 48
1: Sudbo J, Lee JJ, Lippman SM, Mork J, Sagen S, Flatner N, Ristimaki A, Sudbo A, Mao L,
Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ. Non-steroidal anti-inflammatory drugs
and the risk of oral cancer: a nested case-control study. Lancet. 2005 Oct 15-21;366(9494):1359-
66.
2: Sudbo J. Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res.
2004 Nov;2(4):233-42. Review.
3: Kildal W, Risberg B, Abeler VM, Kristensen GB, Sudbo J, Nesland JM, Danielsen HE. betacatenin
_expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in
253 patients. Eur J Cancer. 2005 May;41(8):1127-34. Epub 2005 Apr 14.
4: Lilleby W, Sudbo J, Fossa SD. [Biology and treatment options during the development of
prostate cancer] Tidsskr Nor Laegeforen. 2005 Mar 3;125(5):571-4. Review. Norwegian.
5: Sudbo J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R,
Sigstad E, Davidson B, Reith A, Berner A. Risk markers of oral cancer in clinically normal
mucosa as an aid in smoking cessation counseling. J Clin Oncol. 2005 Mar 20;23(9):1927-33.
6: Sudbo J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral
cancer prevention. Int J Cancer. 2005 Jun 20;115(3):339-45. Review.
7: Lippman SM, Sudbo J, Hong WK. Oral cancer prevention and the evolution of moleculartargeted
drug development. J Clin Oncol. 2005 Jan 10;23(2):346-56. Review.
8: Kildal W, Kaern J, Kraggerud SM, Abeler VM, Sudbo J, Trope CG, Lothe RA, Danielsen HE.
Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation
to clinicopathologic variables. Cancer Genet Cytogenet. 2004 Nov;155(1):25-32.
9: Sudbo J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbo A, Sagen S, Bryne M, El-Naggar A,
Risberg B, Evensen JF, Reith A. The influence of resection and aneuploidy on mortality in oral
leukoplakia. N Engl J Med. 2004 Apr 1;350(14):1405-13.
10: Sudbo J, Reith A, Florenes VA, Nesland JM, Ristimaki A, Bryne M. COX-2 _expression in
striated muscle under physiological conditions.
Oral Dis. 2003 Nov;9(6):313-6.
11: Sudbo J. Non-invasive early diagnosis of oral cavity malignancies.
Anal Cell Pathol. 2003;25(4):157-8.
12: Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM, Lippman
SM. Molecular based treatment of oral cancer.
Oral Oncol. 2003 Dec;39(8):749-58. Review.
13: Sudbo J. Protection of research subjects. N Engl J Med. 2003 Jul 10;349(2):188-92; author
reply 188-92.
48 Hentet fra www.pubmed.gov januar 2006. Ikke uttømmende.
123